Table 2.
Multivariate logistic regression analysis affecting HZN.
| Variable | B | S.E. | Wald | Exp (B) | 95% CI | P | |
|---|---|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||||
| Age | 0.829 | 0.755 | 1.204 | 2.291 | 0.521 | 10.069 | 0.272 |
| Sex | −0.642 | 0.710 | 0.818 | 0.526 | 0.131 | 2.116 | 0.366 |
| The period of initial clinic visit | −0.0352 | 0.448 | 0.617 | 0.703 | 0.292 | 1.692 | 0.432 |
| Combined disease | 0.505 | 0.881 | 0.329 | 1.657 | 0.295 | 9.312 | 0.566 |
| NRS | −0.044 | 0.839 | 0.003 | 0.957 | 0.185 | 4.960 | 0.958 |
| CD8+ | 2.037 | 0.816 | 6.237 | 7.667 | 1.550 | 37.923 | 0.071 |
| CD4+/CD8+ | 2.128 | 0.835 | 6.500 | 8.397 | 1.636 | 43.109 | 0.338 |
| IL-6 | 2.303 | 0.564 | 16.685 | 10.002 | 3.313 | 30.196 | <0.001 |
| Galectin-3 | 1.313 | 0.552 | 5.667 | 3.719 | 1.261 | 10.966 | 0.017 |
NRS, numerical rating score; IL, interleukin; B, standardized coefficient; CI, confidence interval; HZN, herpes zoster neuralgia.